Testing version — LOERadar is in active testing. Features and data may change.
ASTEPRO (AZELASTINE HYDROCHRLORIDE) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
ASTEPRO
NDANot in Orange Book
AZELASTINE HYDROCHRLORIDE | N022371 | MEDA PHARMS
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — 0.1%
▴
SPRAY, METERED;NASAL | Approved: Aug. 31, 2009
No patent or exclusivity listings for this strength.